Puromycin is an aminoglycoside antibiotic isolated from the bacterium Streptomyces alboniger. It inhibits protein synthesis by acting as an analog of the 3’ terminal end of aminoacyl-tRNA. During translation, it incorporates into the growing polypeptide chain at the ribosomal A site, causing premature termination and the release of an incomplete peptide. This agent exhibits antimicrobial, antitrypanosomal, and antineoplastic properties and is widely used in molecular biology research as a selection agent in cell culture to establish stable cell lines expressing the puromycin resistance gene (pac gene).